Clinical Trials List
Protocol NumberHCB301-101
Active
2025-11-01 - 2027-12-31
Phase I
Recruiting3
-
Trial Applicant
STATPLUS, INC.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/08/01
Investigators and Locations
Principal Investigator
Li-Tzong Chen
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 莊博雅 Division of Hematology & Oncology
- TSU-YI CHAO Division of Hematology & Oncology
- HUI-WEN LIU Division of Hematology & Oncology
- 蔡承志 Division of Hematology & Oncology
- Yao-Yu Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- Wei-Wu Chen Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
15 participants
-
Global
30-50 participants
